Project Title: Cuffles blood pressure measurement software (OptiBP):a two-phased study (Project ID: A65932)
Project Description: Hypertensive disorders of pregnancy (HDP) including pre-eclampsia and eclampsia are a leading cause of maternal morbidity and mortality worldwide, accounting for ~14% of maternal deaths- an estimated 62,000 to 77,000 women per year. HDP deaths can be prevented through timely detection and effective management of high blood pressure. Though blood pressure (BP) measurement is recommended as an essential part of all antenatal care (ANC) contacts throughout pregnancy, especially during the third trimester, the ability to... Hypertensive disorders of pregnancy (HDP) including pre-eclampsia and eclampsia are a leading cause of maternal morbidity and mortality worldwide, accounting for ~14% of maternal deaths- an estimated 62,000 to 77,000 women per year. HDP deaths can be prevented through timely detection and effective management of high blood pressure. Though blood pressure (BP) measurement is recommended as an essential part of all antenatal care (ANC) contacts throughout pregnancy, especially during the third trimester, the ability to measure with a functioning blood pressure device, recognize elevated numbers, and provide a referral when warranted remain important barriers to care. WHO is coordinating a multi-country research study to test the accuracy of a cuffless electronic algorithm embedded into a mobile phone application (i.e., OptiBP), to estimate blood pressure among pregnant and non-pregnant populations across three low-resource country settings (Bangladesh, Tanzania, South Africa). The study will be conducted in two phases: -Phase objective: To calibrate and assess the OptiBP algorithms for use in low- and Middle-Income Countries (LMIC) populations and settings.
Principal Investigator : Honorati Masanja
Department Name :
Time frame: (2020-12-09) - (2022-07-31)
World Health Organization (WHO) (Normal)
External Collaborating Partners
None added yet.